Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:13 PM
Ignite Modification Date:
2025-12-24 @ 12:13 PM
NCT ID:
NCT06748261
Eligibility Criteria:
Cardiomyopathy cohort:
* Inclusion Criteria:
1. A clinical diagnosis of cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, cardiac amyloidosis, myocarditis, arrhythmogenic right ventricular cardiomyopathy, and coronary artery disease/ischemic heart disease.
2. At least one CCTA before surgery or implantable device treatment.
* Exclusion Criteria:
1. No recorded diagnosis of cardiomyopathy or undetermined type of cardiomyopathy.
2. A clinical diagnosis of secondary cardiac abnormalities due to other organic or systemic diseases.
3. Surgery or implantable device treatment before CCTA examination.
Control cohort:
* Inclusion Criteria: participants with at least one CCTA examination.
* Exclusion Criteria: clinical diagnosis of cardiovascular diseases (including cardiomyopathy, history of myocardial infarction, history of cardiac surgery, stent implantation, ICD implantation and so on) or secondary cardiac abnormalities due to systemic diseases.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT06748261
Study Brief:
Protocol Section:
NCT06748261